SAGE Therapeutics Inc banner

SAGE Therapeutics Inc
NASDAQ:SAGE

Watchlist Manager
SAGE Therapeutics Inc Logo
SAGE Therapeutics Inc
NASDAQ:SAGE
Watchlist
Price: 8.68 USD Market Closed
Market Cap: $544.9m

Wall St Price Targets

SAGE Price Targets Summary
SAGE Therapeutics Inc

There are no price targets for SAGE.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
SAGE Therapeutics Inc Competitors:
Price Targets
LH6
LHC Group Inc
43% Upside
FAST
Fastenal Co
4% Upside
IPAR
Inter Parfums Inc
21% Upside
SANA
Sana Biotechnology Inc
225% Upside
AFYA
Afya Ltd
17% Upside
CASY
Caseys General Stores Inc
11% Upside

Revenue
Forecast

N/A
Past Growth
57% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat
N/A
Past Growth
57% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat

The compound annual growth rate for Revenue over the next 3 years is 57%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for SAGE Therapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for SAGE Therapeutics Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SAGE's stock price target?
Not Available

SAGE does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for SAGE Therapeutics Inc?
Projected CAGR
57%

The compound annual growth rate for Revenue over the next 3 years is 57%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett